Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00924690 · ClinicalTrials.gov registry record · NA

Colon Cancer Prevention Study

A NA study of Colorectal Cancer, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
207
Enrollment target
1
Study location

NCT00924690: Completed NA study of Colorectal Cancer, sponsored by University of North Carolina, Chapel Hill.

NCT00924690 is a NA study of Colorectal Cancer that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 207 participants, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00924690, a NA study of Colorectal Cancer, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
207 participants
Enrollment target
1
Study location

Study Summary

The goal of this research study is to design messages which can help people learn more about how to prevent colon cancer. Eligible participants will be asked to review a series of short cancer prevention messages and share their opinions on them. Participants also need to fill out a short survey with questions on their background and attitudes and knowledge about physical activity and colon cancer. The whole study can be completed online and will take less than 1 hour. After completing the entire study, participants will receive $25. If you are interested in participating in this study, please visit the following website: https://surveys.chaicore.com/preventcancer/

Conditions Studied

Interventions

  • OTHER Behavioral Messages
  • OTHER Generic Messages

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 207 participants
Start Date 2009-06
Est. Completion 2009-10
Phase NA

What the finished NCT00924690 record still lists

NCT00924690 is an interventional study that assigns participants to a tested intervention. The registered 207 participants enrollment target is mid-sized for trials with a published cap, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (87% lower).

The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 2 interventions - of which Behavioral Messages is the first listed.

NCT00924690 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT00924690 about?

NCT00924690 is a clinical study titled "Colon Cancer Prevention Study". The goal of this research study is to design messages which can help people learn more about how to prevent colon cancer. Eligible participants will be asked to review a series of short cancer prevention messages and share their opinions on them. Participants also need to fill out a short survey wit...

What is the current status of trial NCT00924690?

This trial is currently completed. It is a NA study. The enrollment target is 207 participants. The study started on 2009-06. Estimated completion is 2009-10.

What conditions does trial NCT00924690 study?

This clinical trial studies the following conditions: Colorectal Cancer.

What interventions are being tested in trial NCT00924690?

The interventions under investigation include: Behavioral Messages (OTHER), Generic Messages (OTHER).

Who is sponsoring clinical trial NCT00924690?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00924690 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00924690's enrollment target sits among peer trials

207 145th of 381 higher than 237 of 381 other Colorectal Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04353778 · 207 participants · Phase 1

    Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV

  • NCT05875805 · 207 participants · NA

    A Telehealth Advance Care Planning Intervention

  • NCT06254950 · 207 participants · Phase 2

    A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

  • NCT06904274 · 207 participants · Phase 3

    Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00924690, the US trial registry maintained by the National Library of Medicine. NCT00924690 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.